New website

Our current website has been a bit quiet of late. That’s because we have been hard at work behind the scenes re-designing our website layout and structure. We look forward to sharing our new look with you early in 2022!
Click here to access our current website.

Meet the ADLIFE Team

Because the restrictions imposed by the global pandemic prevent us meeting up in person, it's important that we find different ways to help us get to know each other better. In this Newsletter we meet Gabriela Maxwell, the Principal Investigator at the pilot site in NHS Lanarkshire. Gabriela shares her background and her thoughts about the ADLIFE project with us.

Gabriela Maxwell, the ADLIFE Principal Investigator for NHS Lanarkshire is a Nurse Consultant in Primary Care. Her background is in Primary Care Advanced Nursing Practice (Urgent In and Out of hours care) and in Secondary Care Front Door Services and Critical Care.

Gabriela’s current role involves advising in relation to Nursing in Primary & Community Care services across NHS Lanarkshire and supporting the implementation of the Primary Care Improvement plan. She works closely with team members to provide strategic vision for the development, improvement and delivery of service within NHS Lanarkshire and the Health and Social Care Partnership and further afield, as appropriate. She collaborates on projects related to the development and delivery of specialist educational programmes to meet the needs of nurses and other relevant stakeholders and is involved in various aspects of research. In her clinical practice Gabriela demonstrates expert practice and knowledge in relation to Primary and Community Care.

Gabriela explains ‘I am the ADLIFE Principal Investigator for NHS Lanarkshire and, even though it is a huge learning curve, it is a privilege to represent NHS Lanarkshire and be part of this unique opportunity. I got involved in the project because research and development is an important part of my role. I hope the main benefit ADLIFE will be in empowering patients to manage their condition effectively as well as improving communications between primary and secondary care services to create a more seamless journey for the patient. I think patients will engage well with the project and I hope carers find it helpful. It would also be good if ADLIFE could be used to give patients and carers the opportunity to engage with each other more than they do now and could encourage more peer group support and reduce feelings of social isolation. I am conscious that for health care professionals and patients engaging with the project it might be challenging to put their energy into something that will potentially be used for just the duration of the trial and they might worry about ‘what happens after it’s gone’. But even if this is the case, ADLIFE will contribute to telehealth developments within the wider health service and help to broaden the spectrum of expertise in digital health initiatives for its most appropriate use in the future.